{"id":24748,"date":"2021-03-28T13:02:25","date_gmt":"2021-03-28T11:02:25","guid":{"rendered":"https:\/\/www.satt.fr\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/"},"modified":"2021-03-28T13:02:25","modified_gmt":"2021-03-28T11:02:25","slug":"les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/","title":{"rendered":"Les start-up EverZom, SkinDermic et SideROS au classement des 100 start-up o\u00f9 investir en 2021, dans le magazine Challenges."},"content":{"rendered":"<p style=\"font-weight: 400;\">Pour la douzi\u00e8me ann\u00e9e cons\u00e9cutive,\u00a0<em>Challenges<\/em>\u00a0a publi\u00e9 sa s\u00e9lection des &#8220;100 start-up o\u00f9 investir&#8221;.<\/p>\n<p style=\"font-weight: 400;\">Les start-up cr\u00e9\u00e9es et accompagn\u00e9es par Erganeo EverZom, SkinDermic et SideROS, y figurent cette ann\u00e9e dans le secteur Medtech et Biotech.<\/p>\n<p style=\"font-weight: 400;\">SkinDermic est sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de m\u00e9dicaments innovants pour le traitement des maladies infectieuses et inflammatoires de la peau.<\/p>\n<p style=\"font-weight: 400;\">Everzom est une start-up sp\u00e9cialis\u00e9e dans le domaine de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative, et d\u00e9veloppe un proc\u00e9d\u00e9 innovant de production de v\u00e9sicules extracellulaires (VEs).<\/p>\n<p style=\"font-weight: 400;\">SideROS d\u00e9veloppe des nouvelles mol\u00e9cules pour combattre le cancer.<\/p>\n<p style=\"font-weight: 400;\">Plus que jamais, Erganeo croit en elles et les f\u00e9licite chaleureusement.<\/p>\n<p style=\"font-weight: 400;\"><b><strong>En savoir plus<\/strong><\/b><\/p>\n<ul style=\"font-weight: 400;\">\n<li><a href=\"https:\/\/www.challenges.fr\/start-up\/everzom-la-plateforme-de-bioproduction-d-exosomes_756443\">EVerZom: la plateforme de bioproduction d\u2019exosomes &#8211; Challenges<\/a><\/li>\n<li><a href=\"https:\/\/www.challenges.fr\/start-up\/skindermic-des-innovations-en-virologie-et-en-dermatologie_756615\">SkinDermic: des innovations en virologie et en dermatologie &#8211; Challenges<\/a><\/li>\n<li>SideROS\u00a0:\u00a0<a href=\"https:\/\/www.youtube.com\/watch?v=EA_8gx1mYd8\">https:\/\/www.youtube.com\/watch?v=EA_8gx1mYd8<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Pour la douzi\u00e8me ann\u00e9e cons\u00e9cutive,\u00a0Challenges\u00a0a publi\u00e9 sa s\u00e9lection des &#8220;100 start-up o\u00f9 investir&#8221;. Les start-up cr\u00e9\u00e9es et accompagn\u00e9es par Erganeo EverZom, SkinDermic et SideROS, y figurent cette ann\u00e9e dans le secteur Medtech et Biotech. SkinDermic est sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de m\u00e9dicaments innovants pour le traitement des maladies infectieuses et inflammatoires de la peau. Everzom [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":24128,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567],"tags":[],"class_list":["post-24748","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Les start-up EverZom, SkinDermic et SideROS au classement des 100 start-up o\u00f9 investir en 2021, dans le magazine Challenges. - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sami Nouili\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/\"},\"author\":{\"name\":\"Sami Nouili\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a0aa411683249636732f5b721e12aa53\"},\"headline\":\"Les start-up EverZom, SkinDermic et SideROS au classement des 100 start-up o\u00f9 investir en 2021, dans le magazine Challenges.\",\"datePublished\":\"2021-03-28T11:02:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/\"},\"wordCount\":170,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/03\/Challenges_Erganeo-Startup.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/\",\"url\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/\",\"name\":\"Les start-up EverZom, SkinDermic et SideROS au classement des 100 start-up o\u00f9 investir en 2021, dans le magazine Challenges. - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/03\/Challenges_Erganeo-Startup.png\",\"datePublished\":\"2021-03-28T11:02:25+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a0aa411683249636732f5b721e12aa53\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/03\/Challenges_Erganeo-Startup.png\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/03\/Challenges_Erganeo-Startup.png\",\"width\":540,\"height\":432},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les start-up EverZom, SkinDermic et SideROS au classement des 100 start-up o\u00f9 investir en 2021, dans le magazine Challenges.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a0aa411683249636732f5b721e12aa53\",\"name\":\"Sami Nouili\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/sami-nouilierganeo-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les start-up EverZom, SkinDermic et SideROS au classement des 100 start-up o\u00f9 investir en 2021, dans le magazine Challenges. - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/","twitter_misc":{"Written by":"Sami Nouili","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/"},"author":{"name":"Sami Nouili","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a0aa411683249636732f5b721e12aa53"},"headline":"Les start-up EverZom, SkinDermic et SideROS au classement des 100 start-up o\u00f9 investir en 2021, dans le magazine Challenges.","datePublished":"2021-03-28T11:02:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/"},"wordCount":170,"image":{"@id":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/03\/Challenges_Erganeo-Startup.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/","url":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/","name":"Les start-up EverZom, SkinDermic et SideROS au classement des 100 start-up o\u00f9 investir en 2021, dans le magazine Challenges. - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/03\/Challenges_Erganeo-Startup.png","datePublished":"2021-03-28T11:02:25+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a0aa411683249636732f5b721e12aa53"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/03\/Challenges_Erganeo-Startup.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/03\/Challenges_Erganeo-Startup.png","width":540,"height":432},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/les-start-up-everzom-skindermic-et-sideros-au-classement-des-100-start-up-ou-investir-en-2021-dans-le-magazine-challenges\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Les start-up EverZom, SkinDermic et SideROS au classement des 100 start-up o\u00f9 investir en 2021, dans le magazine Challenges."}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a0aa411683249636732f5b721e12aa53","name":"Sami Nouili","url":"https:\/\/www.satt.fr\/en\/author\/sami-nouilierganeo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/24748","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=24748"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/24748\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/24128"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=24748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=24748"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=24748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}